"Centro de Atención Médica Oncológica, especializados en la investigación, el diagnóstico y el tratamiento. Buscamos mejorar la calidad de vida de los pacientes y sus familias a través de una atención integral, cálida y transparente."

During the past decade, ONCOCENTRO APYS; Oncología conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ONCOCENTRO APYS; Oncología" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "EirGenix, Inc." with 1 trials sponsored and "Nektar Therapeutics" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ONCOCENTRO APYS; Oncología" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "European Network for Gynaecological Oncological Trial Groups" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "ONCOCENTRO APYS; Oncología" are "Breast Cancer" (2 trials), "Renal Cell Carcinoma" (2 trials), "Active Systemic Lupus Erythematosus" (1 trials), "Cervical Cancer" (1 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "ONCOCENTRO APYS; Oncología" in a lesser frequency.

Most popular intervention types in "ONCOCENTRO APYS; Oncología" are "Drug" (12 trials), "Biological" (3 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Carboplatin" (4 trials), "Paclitaxel" (4 trials), "Docetaxel" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "ONCOCENTRO APYS; Oncología" are 9 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "ONCOCENTRO APYS; Oncología". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in ONCOCENTRO APYS; Oncología, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ONCOCENTRO APYS; Oncología, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".